Indication
Heart Failure
The Heart Failure pipeline: 76 tracked drugs, 15 approved for this indication.
15 approved / phase 418 Phase 31 Phase 2/324 Phase 26 Phase 1/211 Phase 11 preclinical / unstaged
Compare the share prices of listed companies in Heart Failure →
Total attributable cost
$27.7B
$3,594/patient
Drug spend
$9.1B
$1,188/patient
33% of total cost is drugs
All severities (2021-2023 NHANES cycle) · US